Rare diseases
Investigational molecules
Locations
Waehringer Guertel 18-20, Alsergrund, 1090 Vienna, Austria
Medical University Of Vienna in Vienna, Austria specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Breast cancer, Non-small cell lung cancer, and other specialisations. This site conducts important research.
The division focuses on evaluating a novel HER3‑DXd in patients with advanced cancers that have spread to the central nervous system.
The studies are conducted at Medical University of Vienna with strong collaboration between academic investigators and commercial partners.
Clinical investigations address brain metastases arising from Metastatic Breast Cancer and Non‑Small Cell Lung Cancer, aiming to improve treatment outcomes inside the skull.
Over 184 investigators contribute to these trials, reflecting the site’s extensive expertise in neuro‑oncology.
A dedicated cohort investigates patients with solid tumors and untreated leptomeningeal disease, testing whether the HER3‑conjugate can extend survival.
The program highlights the department’s commitment to tackling rare and aggressive CNS complications of cancer.
Clinical trials currently enrolling participants at this site.
AustriaPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
AustriaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
AustriaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
AustriaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
AustriaStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
AustriaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
AustriaA study of navenibart for long-term safety in patients with hereditary angioedema
AustriaA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
AustriaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
AustriaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
